Promacta — Blue Cross Blue Shield Of Alabama
12 indications indexed for this drug.
- First Line Therapy In Severe Aplastic AnemiaView coverage criteria
- Hematopoietic Syndrome Of Acute Radiation Syndrome Hs ArsView coverage criteria
- Hepatitis C Associated ThrombocytopeniaView coverage criteria
- Immune Idiopathic Thrombocytopenia ItpView coverage criteria
- Immune Thrombocytopenia ItpView coverage criteria
- Other Fda Labeled Or Compendia Supported IndicationsView coverage criteria
- Other IndicationsView coverage criteria
- Other Severe Aplastic AnemiaView coverage criteria
- Persistent Or Chronic ItpView coverage criteria
- Severe Aplastic AnemiaView coverage criteria
- Thrombocytopenia In Hepatitis CView coverage criteria
- Thrombocytopenia In Patients With Chronic Liver Disease WhoView coverage criteria